166 related articles for article (PubMed ID: 30868268)
1. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Respond to author.
Zhang K; Gao C; Tang Q
Support Care Cancer; 2019 Sep; 27(9):3171-3172. PubMed ID: 30868268
[No Abstract] [Full Text] [Related]
2. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
[TBL] [Abstract][Full Text] [Related]
3. Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.
Cook G
Bone Marrow Transplant; 2015 Oct; 50(10):1269-70. PubMed ID: 26237169
[No Abstract] [Full Text] [Related]
4. Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
Moor I; Bacher VU; Jeker B; Taleghani BM; Mueller BU; Keller P; Betticher D; Egger T; Novak U; Pabst T
Bone Marrow Transplant; 2018 Dec; 53(12):1599-1602. PubMed ID: 29884856
[No Abstract] [Full Text] [Related]
5. The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
Manjappa S; Fiala MA; King J; Kohnen DA; Vij R
Bone Marrow Transplant; 2018 Nov; 53(11):1483-1486. PubMed ID: 29795420
[No Abstract] [Full Text] [Related]
6. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.
Rosko A; Hofmeister C; Benson D; Efebera Y; Huang Y; Gillahan J; Byrd JC; Burd CE
Bone Marrow Transplant; 2015 Oct; 50(10):1379-81. PubMed ID: 26121107
[No Abstract] [Full Text] [Related]
7. Stem cell transplantation in multiple myeloma.
Björkstrand B
Hematology; 2005; 10 Suppl 1():26-8. PubMed ID: 16188627
[No Abstract] [Full Text] [Related]
8. Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.
El Fakih R; Fox P; Popat U; Nieto Y; Shah N; Parmar S; Oran B; Ciurea S; Kebriaei P; Hosing C; Ahmed S; Shah J; Orlowski R; Champlin R; Qazilbash M; Bashir Q
Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):472-6. PubMed ID: 25963284
[TBL] [Abstract][Full Text] [Related]
9. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis.
Shah N; Shi Q; Williams LA; Mendoza TR; Wang XS; Reuben JM; Dougherty PM; Bashir Q; Qazilbash MH; Champlin RE; Cleeland CS; Giralt SA
Biol Blood Marrow Transplant; 2016 Feb; 22(2):226-231. PubMed ID: 26253006
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy in multiple myeloma.
Bladé J; Vesole DH; Gertz Morie
Blood; 2003 Nov; 102(10):3469-70. PubMed ID: 12893762
[No Abstract] [Full Text] [Related]
11. Tandem bone marrow transplantation in multiple myeloma.
Chng WJ
N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
[No Abstract] [Full Text] [Related]
12. KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation.
Cowan AJ; Green DJ; Karami M; Becker PS; Tuazon S; Coffey DG; Hyun TS; Libby EN; Gopal AK; Holmberg LA
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):602-609. PubMed ID: 32457024
[TBL] [Abstract][Full Text] [Related]
13. Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.
Mustafa Ali M; Corrigan DM; Rybicki LA; Yurch MA; Cherni K; Liu H; Dean R; Hamilton B; Pohlman B; Andresen S; Kalaycio M; Bolwell BJ; Majhail NS; Sobecks R
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):253-256. PubMed ID: 29705567
[No Abstract] [Full Text] [Related]
14. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
Landau H; Wood K; Chung DJ; Koehne G; Lendvai N; Hassoun H; Lesokhin A; Hoover E; Zheng J; Devlin SM; Giralt S
Leuk Lymphoma; 2016 Aug; 57(8):1781-5. PubMed ID: 26758672
[TBL] [Abstract][Full Text] [Related]
15. Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Nooka AK; Harvey RD; Langston A; Collins H; Lonial S; Kaufman JL
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e59-63. PubMed ID: 24378319
[No Abstract] [Full Text] [Related]
16. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
Tacchetti P; Pantani L; Patriarca F; Petrucci MT; Zamagni E; Dozza L; Galli M; Di Raimondo F; Crippa C; Boccadoro M; Barbato S; Tosi P; Narni F; Montefusco V; Testoni N; Spadano A; Terragna C; Pescosta N; Marzocchi G; Cellini C; Galieni P; Ronconi S; Gobbi M; Catalano L; Lazzaro A; De Sabbata G; Cangialosi C; Ciambelli F; Musto P; Elice F; Cavo M;
Lancet Haematol; 2020 Dec; 7(12):e861-e873. PubMed ID: 33242443
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Shah N; Callander N; Ganguly S; Gul Z; Hamadani M; Costa L; Sengsayadeth S; Abidi M; Hari P; Mohty M; Chen YB; Koreth J; Landau H; Lazarus H; Leather H; Majhail N; Nath R; Osman K; Perales MA; Schriber J; Shaughnessy P; Vesole D; Vij R; Wingard J; Giralt S; Savani BN;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1155-66. PubMed ID: 25769794
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Li QS; Lapen K; Mao JJ
Pain Med; 2020 Mar; 21(3):636-642. PubMed ID: 31498394
[TBL] [Abstract][Full Text] [Related]
19. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
Garderet L; Iacobelli S; Koster L; Goldschmidt H; Johansson JE; Bourhis JH; Krejci M; Leleu X; Potter M; Blaise D; Koenecke C; Peschel C; Radocha J; Metzner B; Lenain P; Schäfer-Eckart K; Pohlreich D; Grasso M; Caillot D; Einsele H; Ladetto M; Schönland S; Kröger N
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1372-1378. PubMed ID: 29408334
[TBL] [Abstract][Full Text] [Related]
20. Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experience.
Jurgensen-Rauch A; Gibbs S; Farrell M; Aries J; Grantham M; Eccersley L; Gribben J; Hallam S; Oakervee H; Cavenagh J; Davies J; Sive J
Br J Haematol; 2021 Apr; 193(2):420-423. PubMed ID: 33713421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
